Aedes aegypti is a vector of dengue, chikungunya, and Zika viruses. Current vector control strategies such as community engagement, source reduction, and insecticides have not been sufficient to prevent viral outbreaks. Thus, interest in novel strategies involving genetic engineering is growing. Female mosquitoes rely on flight to mate with males and obtain a bloodmeal from a host. We hypothesized that knockout of genes specifically expressed in female mosquitoes associated with the indirect flight muscles would result in a flightless female mosquito.
A function that is critical for both reproduction and survival in females is flight, as flight is required for mating, obtaining a blood meal, and escaping from water after eclosion. AeAct-4 was identified previously as a female-and pupal-specific gene, with expression in the indirect flight muscles [24] . Other work has identified a male-specific actin gene [25] and male-specific myosin gene [26] related to flight, offering up the possibility that male and female flight in Aedes mosquitoes is controlled by these sex-specific genes.
To demonstrate the importance of female-specific actin and myosin genes to Ae. aegypti female flight, we used CRISPR/Cas9 to generate heritable loss-of-function alleles in AeAct-4 and the female-specific myosin gene, along with a third gene, Aeflightin, expressed in both males and females. Phenotypic analysis of individuals homozygous for each introduced mutation in AeAct-4 or the female-specific myosin confirmed that flight defects were both complete and likely restricted to females. Disruption of Aeflightin was associated with loss of flight in both sexes. The data support the pursuit of novel genetic strategies geared specifically for disrupting female flight in Ae. aegypti.
Materials and methods:
Insect rearing:
The Liverpool strain of Ae. aegypti was used for embryonic microinjections and outcrossing of mutant individuals. All mosquitoes were reared at 28°C and 80-85% humidity, with a 14/10 h light/dark light cycle. Ground up fish food (Tetra, Blacksburg, VA) was supplied throughout the aquatic developmental stages, and a cotton ball soaked with 10% sucrose solution was supplied during the adult stage. Flightless mosquitoes were supplied with raisins as the source of sucrose. Defibrinated sheep blood (Colorado Serum Company, Denver, CO) was offered for blood feeding, via a parafilm membrane feeder. Videos were taken with a Canon Rebel T3i digital camera.
Guide RNA design and synthesis:
Guide RNAs were designed by hand with the DNASTAR SeqBuilder Pro software (Madison, WI), using the appropriate gene sequence acquired through VectorBase. Primers used to make each sgRNA were ordered through the IDT custom DNA oligos web ordering service.
Guide RNA synthesis was performed as previously described [20] . Briefly, Q5 High-Fidelity DNA Polymerase (New England BioLabs Inc., Ipswich, MA) was used for the PCR reaction, followed by the NucleoSpin Gel and PCR Clean-Up kit protocol (Machery-Nagel, Bethlehem, PA), the MEGAscript T7 Transcription kit protocol, and the MEGAclear Transcription Clean-Up kit protocol (Thermo Fisher Scientific, Waltham, MA). All sgRNAs were quantified, aliquoted, and stored at -80°C. A list of oligos used to make each sgRNA are listed in table 2.
Embryo microinjections:
Borosilicate glass capillaries (World Precision Instruments Inc., Sarasota, FL) were pulled and beveled using the Sutter P-2000 Micropipette Puller and Sutter BV-10 Micropipette Beveller (Sutter Instrument Co., Novato, CA). Embryo microinjections were performed using a Leica DM 1000 LED Micromanipulator (Leica Biosystems, Buffalo Grove, IL) and FemptoJet 4i Microinjector (Eppendorf, Hauppauge, NY). Purified Cas9 protein (400 ng/μl) (PNA Bio, Thousand Oaks, CA) and sgRNAs (100 ng/μl) were combined into injection mixes, incubated at 37°C for 30 minutes, and centrifuged at max speed, 4°C, for a minimum of 45 minutes. Injections were performed into the posterior end of embryos that were less than three hours old. Injected embryos were either harvested at 24 hours (for embryo assays) or hatched after five days. Hatched G0 survivors were outcrossed to the wild type Liverpool strain.
DNA extraction, PCR, HRMA, and Sanger sequencing:
Genomic DNA was extracted from non-injected or sgRNA-injected Liverpool embryos following the Nucleospin Tissue kit protocol (Machery-Nagel, Bethlehem, PA). Embryo assays were performed with the LightScanner Master Mix kit (Idaho Technology Inc., Salt Lake City, UT), and mutant detection was performed on adult legs with the Phire Animal Tissue Direct PCR kit (Thermo Fisher Scientific, Waltham, MA) with added LCGreen Plus+ Melting dye (Idaho Technology Inc., Salt Lake City, UT). All samples were amplified with the C1000 Touch Thermal Cycler (Bio-rad, Hercules, CA) before being analyzed with the LightScanner Call-IT 2.0 software on the LightScanner instrument (Idaho Technology Inc., Salt Lake City, UT). Sanger sequencing was performed at the Laboratory for Genomic Technologies (Institute for Plant Genomics and Biotechnology, Texas A&M University, College Station, TX) and chromatograms were analyzed using Chromas software (Technelysium, Australia). A list of primers used are located in table 1.
Flight determination:
To assess flight, pupae were placed in plastic ketchup containers (with the stick of a Q-tip to aid in escaping from the water) in 5-quart plastic buckets (Home Depot) designed with a mesh covering over the top and a sock for internal access on the side. The plastic lining of the bucket inhibited the mosquitoes from climbing up the sides towards the mesh covering (adapted from Chae et al, "CRISPR/Cas9-driven Gene Knockout of Aedes aegypti Pupae-specific Stretchin Resulted in Flightless Mosquitoes", in preparation). Flying mosquitoes that could fly up to the mesh covering were removed from the plastic bucket, and 24 hours was allowed to pass after the last pupae emerged before classifying the remaining mosquitoes as flightless. Dead adults whose flight phenotype could not be confirmed were not analyzed for a genotype.
Results:
Since female mosquitoes rely on flight to obtain a blood meal and mate, disrupting femalespecific flight would prevent females from reproducing, or transmitting viruses. AeAct-4 has been characterized as a female-and pupal-specific flight protein that is expressed in the indirect flight muscles [24] . Analysis of RNA-seq data from the developmental transcriptome of Ae. aegypti [27] led us to select two other hypothesized flight genes, based on female-specific expression or pupal-specific expression.
The first gene, AAEL005656, is a paralog to the gene myo-sex (AAEL021838), a malespecific myosin gene located in the M locus on chromosome one [26] and required for male flight [28] . As AAEL005656 was found to be expressed specifically in female pupae, we reasoned that it might be similarly critical for female flight, and refer to this gene as myo-fem. The second gene, AAEL004249, is expressed in both males and females, but is pupal-specific. In Drosophila melanogaster, the ortholog to AAEL004249, flightin, has been shown to be expressed in the indirect flight muscles [29] , with knockout resulting in a loss of flight ability [30] . We reasoned that despite lacking female specificity, Aeflightin may be a good target for disrupting female flight, so long as a male-specific rescue can be performed.
For each of these three target genes, we designed multiple sgRNAs. Due to high nucleotide sequence similarity between AeAct-4 and other actin paralogs, we performed a multiple sequence alignment prior to sgRNA design. Eleven paralogs with >60% nucleotide sequence identity to AeAct-4 were aligned to identify PAM sites that were unique to AeAct-4. For myo-fem, guide RNAs were designed to target the motor domain to ensure disruption of myosin function. For Aeflightin, guide RNAs were designed to each exon as we did not identify any paralogous genes in the Ae. aegypti genome.
Following in vitro synthesis, sgRNAs were complexed with Cas9 protein and injected in groups of 3-4 into Ae. aegypti embryos, which were harvested after 24 hours. To identify those batches capable of inducing strong gene disruption, genomic DNA from injected embryos was used as a template for PCR/HRMA of the target region (figure 1). For AeAct-4, we identified one location that was disrupted by a cluster of guide RNAs. For myo-fem and Aeflightin, we identified two clusters of guide RNAs with detectable editing in embryos.
For each mixture of guide RNAs that displayed editing activity, we repeated embryo microinjections and this time allowed the embryos to hatch after five days. Survivors were outcrossed to the parental Liverpool strain to obtain G1 progeny. G1 adults were screened via PCR/HRMA and Sanger sequencing for out-of-frame mutations (table 3) . Deletions predicted to result in a frameshift mutation were recovered for AeAct-4, myo-fem, and Aeflightin (figure 2).
Genotyped adults with out-of-frame mutations were outcrossed to the parental strain for two generations followed by an intercross of heterozygous individuals (figure 3). Since we were targeting female-specific genes, we sought to observe the ratio of males to females during development to ensure there was no early mortality associated with either sex. For knockout of all three of our target genes, the observed male to female ratios were not significantly different from the expected 1:1 ratio (AeAct-4 p = 0.8124; myo-fem p = 0.9390; Aeflightin p = 0.0828, Chi square analysis). This indicates there was no significant female-or male-associated mortality prior to the adult stage associated with knockout of these genes. As all observations of flight behavior were made without consideration for genotype, we sought to determine whether there was a relationship between the ability of our mosquitoes to fly and inheriting one or two copies of each loss-of-function mutation. A genotypic analysis of all flightless individuals and a subset of flying individuals was performed for each cross (tables 4-6, figure 6 ). For both AeAct-4 (table 4) and myo-fem (table 5), males homozygous for the loss-offunction mutations could fly (though for AeAct-4 there was also a single homozygous male that could not fly). However, all homozygous AeAct-4 Δ10 females were flightless (100%). Interestingly, while most heterozygous AeAct-4 Δ10 females could fly (92%, only two were flightless), this was not the case for myo-fem Δ11 , where most heterozygous (88%) and all homozygous (100%) females were flightless. The flying to flightless ratio did not differ significantly from the expected ratio for AeAct-4 (p = 0.5300, Chi square analysis), suggesting the flightless phenotype was recessive in this case. Due to the increase in flightless heterozygous females for myo-fem, the flying to flightless ratio was significantly different from the expected ratio (p < 0.0001, Chi square analysis), confirming that defects in myo-fem are not recessive. As the Aeflightin gene is tightly linked to the kmo gene involved in eye pigmentation, Aeflightin mutants were outcrossed to a kynurenine 3-monooxygenase (kmo) knockout strain [20] to help track the corresponding genotypes. This aided in phenotypic identification of homozygous kmo individuals who do not carry the Aeflightin mutation, as well as maintenance of a transheterozygous line. At G4, low levels of recombination between kmo and Aeflightin were both expected and observed (table 6). The white-and black-eyed ratio did not differ significantly from the expected ratio (p = 0.4474, Chi square analysis) as the kmo loss-of-function is completely recessive. White-eyed adults hypothesized as wild type for Aeflightin based on HRMA results were confirmed via sequencing, while black-eyed adults that could fly were confirmed as heterozygous for either the Aeflightin Δ4 or Aeflightin Δ5 mutations, with only a small portion of heterozygous individuals (8%) that were flightless. The flying to flightless ratio did not differ significantly from the expected ratio for Aeflightin (p = 0.0008, Chi square analysis). Critically, all individuals confirmed as transheterozygous (Aeflightin Δ4/Δ5 ) were flightless, confirming that Aeflightin is required for flight in both males and female Ae. aegypti.
Discussion:
Our results indicate successful knockout of three flight-specific genes, two of which are expressed predominantly in females (AeAct-4 and myo-fem). Interestingly, we found that while AeAct-4 and Aeflightin were haplosufficient, two intact copies of myo-fem appeared to be required for normal female flight. We note though that our approach allowed 24 hours after the last adult emerged for all mosquitoes to gain the ability to fly. For myo-fem, there were a few individuals who subsequently gained the ability to fly up to 48 hours after all flyers had been removed. These individuals seemed to have a delay (> 24 hours post-eclosion) in gaining flight ability, suggesting that a single copy of myo-fem, while insufficient to program the normal timing of development of the flight muscles, may be sufficient provided the female can survive long enough. If myo-fem is truly haploinsufficient, this opens the door for development of strong synthetic sex distorters for suppressing Ae. aegypti populations. Despite the lack of female specificity for the third gene, Aeflightin, we reason that this still represents a useful target so long as a male-specific rescue can be performed to fully restore male flight.
Flightless Ae. aegypti have been developed previously through the transgenic overexpression of the tTa transactivator specifically in the female flight muscle [31] . In this case, the promoter region of AeAct-4 was used to control transgene expression, however transgenic males were found to have decreased mating competitiveness in field cage trials [32, 33] .
Variability in the level of transgene overexpression also resulted in incomplete penetrance of the flightless phenotype. In our case, disruption of the AeAct-4 gene through heritable gene editing resulted in a completely penetrant phenotype without the requirement for continuous transgene expression. However, it will be important to assess the fitness of the males homozygous for either the AeAct-4 or myo-fem mutations, as both AeAct-4 and myo-fem show low levels of transcription in male pupae [27] , and so it is possible that male flight, while not disrupted, could be reduced in these individuals when more intensive flying is required.
Disrupting flight specifically in female mosquitoes could be used to achieve sex distortion of the adult population. This is conceptually similar to other sex distortion approaches such as the X-shredding system based on the I-PpoI homing endonuclease when active only during male meiosis, and shown to be capable of producing >95% male progeny [34] . Other examples of targets for sex-ratio distortion in An. gambiae include female reproductive genes [35, 36] and the female transcript of doublesex, which causes an intersex phenotype and complete sterility [37] , however the recessive nature of these phenotypes reduces their power as sex distorters. In Drosophila melanogaster, disruption of other genes causing female fertility or embryonic lethality [17] have been shown to skew the sex-ratio towards males, while in Ae. aegypti overexpression of the male sex determining factor nix has been proposed as a method of sex distortion [38] . We note that the development of a sex-ratio distortion approach that targets female-specific flight would allow for maximum competition for resources during larval development as well as allow active monitoring of the number of females doomed to flightlessness, while at the same time preventing the adult female from reproducing and potentially transmitting deadly pathogens. With the data presented here and with further analysis, we can begin to consider or develop an approach for a mechanism of population control that targets female-specific flight for the Ae. AeAct-4; B, myo-fem; C, Aeflightin) . The number above each bar represents the number of individuals displaying the flightless phenotype, and were confirmed for the specified genotype via sequencing. 
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